Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.

Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK; Diabetic Retinopathy Clinical Research Network.

Am J Ophthalmol. 2008 May;145(5):894-901. doi: 10.1016/j.ajo.2007.12.025. Epub 2008 Feb 21.

2.

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.

Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD.

Arch Ophthalmol. 2007 Apr;125(4):469-80.

3.

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.

PKC-DRS2 Group, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.

Ophthalmology. 2006 Dec;113(12):2221-30. Epub 2006 Sep 20.

PMID:
16989901
4.

An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial.

Gardner TW, Sander B, Larsen ML, Kunselman A, Tenhave T, Lund-Andersen H, Reimers J, Hubbard L, Blankenship GW, Quillen DA, Brod RD, Wilmarth MH, Post-Hansen H, Parving HH, Davis MD.

Curr Eye Res. 2006 Jun;31(6):535-47.

PMID:
16769613
5.

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR.

Diabetologia. 2006 Aug;49(8):1761-9. Epub 2006 May 31.

PMID:
16736131
6.
7.

The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.

Chew EY, Ferris FL 3rd, Csaky KG, Murphy RP, Agrón E, Thompson DJ, Reed GF, Schachat AP.

Ophthalmology. 2003 Sep;110(9):1683-9.

PMID:
13129862
9.

The 14-year incidence of visual loss in a diabetic population.

Moss SE, Klein R, Klein BE.

Ophthalmology. 1998 Jun;105(6):998-1003.

PMID:
9627648
10.

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C.

N Engl J Med. 1993 Sep 30;329(14):977-86.

11.

Ten-year incidence of visual loss in a diabetic population.

Moss SE, Klein R, Klein BE.

Ophthalmology. 1994 Jun;101(6):1061-70.

PMID:
8008348
12.

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

Klein R, Klein BE, Moss SE, Davis MD, DeMets DL.

Ophthalmology. 1984 Dec;91(12):1464-74.

PMID:
6521986
13.

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy.

Klein R, Klein BE, Moss SE, Davis MD, DeMets DL.

JAMA. 1988 Nov 18;260(19):2864-71.

PMID:
3184351
16.

Supplemental Content

Support Center